A comparison of the Charlson comorbidity index derived from medical records and claims data from patients undergoing lung cancer surgery in Korea

A population-based investigation

Hyun Ju Seo, Seok-Jun Yoon, Sang Il Lee, Kun Sei Lee, Young Ho Yun, Eun Jung Kim, In Hwan Oh

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: Calculating the Charlson comorbidity index (CCI) from medical records is a time-consuming and expensive process. The objectives of this study are to 1) measure agreement between medical record and claims data for CCI in lung cancer patients and 2) predict health outcomes of lung cancer patients based on CCIs from both data sources. Methods: We studied 392 patients who underwent surgery for pathologic stages I-III of lung cancer. The kappa value was used to measure the agreement between the 17 comorbidities of the CCI prevalence obtained from medical records and claims data. Multiple linear regression analyses were used to evaluate the relationships between CCI and length of stay and reimbursement cost. Results: Out of 17 comorbidities identified in the Charlson comorbidity index, ten had a higher prevalence, four had a lower prevalence and three had a similar prevalence in claims data to those of medical records. The kappa values calculated from the two databases ranged from 0.093 to 0.473 for nine comorbidities. In predicting length of stay and reimbursement cost after surgical resection for lung cancer patients, the CCI scores derived from both the medical records and claims data were not statistically significant. Conclusions: Poor agreement between medical record data and claims data may result from different motivations for collecting data. Further studies are needed to determine an appropriate method for predicting health outcomes based on these data sources.

Original languageEnglish
Article number236
JournalBMC Health Services Research
Volume10
DOIs
Publication statusPublished - 2010 Aug 17

Fingerprint

Korea
Medical Records
Comorbidity
Lung Neoplasms
Population
Information Storage and Retrieval
Length of Stay
Costs and Cost Analysis
Health
Linear Models
Regression Analysis
Databases

ASJC Scopus subject areas

  • Health Policy

Cite this

A comparison of the Charlson comorbidity index derived from medical records and claims data from patients undergoing lung cancer surgery in Korea : A population-based investigation. / Seo, Hyun Ju; Yoon, Seok-Jun; Lee, Sang Il; Lee, Kun Sei; Yun, Young Ho; Kim, Eun Jung; Oh, In Hwan.

In: BMC Health Services Research, Vol. 10, 236, 17.08.2010.

Research output: Contribution to journalArticle

@article{7dfc72c3daa84be981775ac7a55272f5,
title = "A comparison of the Charlson comorbidity index derived from medical records and claims data from patients undergoing lung cancer surgery in Korea: A population-based investigation",
abstract = "Background: Calculating the Charlson comorbidity index (CCI) from medical records is a time-consuming and expensive process. The objectives of this study are to 1) measure agreement between medical record and claims data for CCI in lung cancer patients and 2) predict health outcomes of lung cancer patients based on CCIs from both data sources. Methods: We studied 392 patients who underwent surgery for pathologic stages I-III of lung cancer. The kappa value was used to measure the agreement between the 17 comorbidities of the CCI prevalence obtained from medical records and claims data. Multiple linear regression analyses were used to evaluate the relationships between CCI and length of stay and reimbursement cost. Results: Out of 17 comorbidities identified in the Charlson comorbidity index, ten had a higher prevalence, four had a lower prevalence and three had a similar prevalence in claims data to those of medical records. The kappa values calculated from the two databases ranged from 0.093 to 0.473 for nine comorbidities. In predicting length of stay and reimbursement cost after surgical resection for lung cancer patients, the CCI scores derived from both the medical records and claims data were not statistically significant. Conclusions: Poor agreement between medical record data and claims data may result from different motivations for collecting data. Further studies are needed to determine an appropriate method for predicting health outcomes based on these data sources.",
author = "Seo, {Hyun Ju} and Seok-Jun Yoon and Lee, {Sang Il} and Lee, {Kun Sei} and Yun, {Young Ho} and Kim, {Eun Jung} and Oh, {In Hwan}",
year = "2010",
month = "8",
day = "17",
doi = "10.1186/1472-6963-10-236",
language = "English",
volume = "10",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "BioMed Central",

}

TY - JOUR

T1 - A comparison of the Charlson comorbidity index derived from medical records and claims data from patients undergoing lung cancer surgery in Korea

T2 - A population-based investigation

AU - Seo, Hyun Ju

AU - Yoon, Seok-Jun

AU - Lee, Sang Il

AU - Lee, Kun Sei

AU - Yun, Young Ho

AU - Kim, Eun Jung

AU - Oh, In Hwan

PY - 2010/8/17

Y1 - 2010/8/17

N2 - Background: Calculating the Charlson comorbidity index (CCI) from medical records is a time-consuming and expensive process. The objectives of this study are to 1) measure agreement between medical record and claims data for CCI in lung cancer patients and 2) predict health outcomes of lung cancer patients based on CCIs from both data sources. Methods: We studied 392 patients who underwent surgery for pathologic stages I-III of lung cancer. The kappa value was used to measure the agreement between the 17 comorbidities of the CCI prevalence obtained from medical records and claims data. Multiple linear regression analyses were used to evaluate the relationships between CCI and length of stay and reimbursement cost. Results: Out of 17 comorbidities identified in the Charlson comorbidity index, ten had a higher prevalence, four had a lower prevalence and three had a similar prevalence in claims data to those of medical records. The kappa values calculated from the two databases ranged from 0.093 to 0.473 for nine comorbidities. In predicting length of stay and reimbursement cost after surgical resection for lung cancer patients, the CCI scores derived from both the medical records and claims data were not statistically significant. Conclusions: Poor agreement between medical record data and claims data may result from different motivations for collecting data. Further studies are needed to determine an appropriate method for predicting health outcomes based on these data sources.

AB - Background: Calculating the Charlson comorbidity index (CCI) from medical records is a time-consuming and expensive process. The objectives of this study are to 1) measure agreement between medical record and claims data for CCI in lung cancer patients and 2) predict health outcomes of lung cancer patients based on CCIs from both data sources. Methods: We studied 392 patients who underwent surgery for pathologic stages I-III of lung cancer. The kappa value was used to measure the agreement between the 17 comorbidities of the CCI prevalence obtained from medical records and claims data. Multiple linear regression analyses were used to evaluate the relationships between CCI and length of stay and reimbursement cost. Results: Out of 17 comorbidities identified in the Charlson comorbidity index, ten had a higher prevalence, four had a lower prevalence and three had a similar prevalence in claims data to those of medical records. The kappa values calculated from the two databases ranged from 0.093 to 0.473 for nine comorbidities. In predicting length of stay and reimbursement cost after surgical resection for lung cancer patients, the CCI scores derived from both the medical records and claims data were not statistically significant. Conclusions: Poor agreement between medical record data and claims data may result from different motivations for collecting data. Further studies are needed to determine an appropriate method for predicting health outcomes based on these data sources.

UR - http://www.scopus.com/inward/record.url?scp=77955475540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955475540&partnerID=8YFLogxK

U2 - 10.1186/1472-6963-10-236

DO - 10.1186/1472-6963-10-236

M3 - Article

VL - 10

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

M1 - 236

ER -